AGL - NYSE
Agilon Health, Inc.
$95.23
+15%agilon health, inc. offers healthcare services for seniors through primary care physicians in the communities of the United States. As of December 31, 2021, it served approximately 238,000 senior members, which included 186,300 medicare advantage members and 51,700 medicare fee-for-service beneficiaries. The company was formerly known as Agilon Health Topco, Inc. and changed its name to agilon health, inc. in March 2021. agilon health, inc. was founded in 2016 and is based in Austin, Texas.
At a Glance
Live Snapshotagl
Income Tax Expense
Last Annual Value
1.25M
3-Year CAGR
-9%
5-Year CAGR
8%
10-Year CAGR
22%
Agilon Health, Inc. Competitors Analysis of Income Tax Expense
| Company | Income Tax Expense | CAGR 3Y | CAGR 5Y | CAGR 10Y | |
|---|---|---|---|---|---|
Agilon Health, Inc. NYSE:AGL | 1.25M | 16.5% | 7.1% | N/A | |
 Enhabit, Inc. NYSE:EHAB | 4.00M | N/A | -35.2% | N/A | |
 Humacyte, Inc. NASDAQ:HUMA | 0.00 | N/A | N/A | N/A | |
 Aura Biosciences, Inc. NASDAQ:AURA | 108.00K | -7.6% | N/A | N/A | |
 Cross Country Healthcare, Inc. NASDAQ:CCRN | 11.34M | -27.9% | 56.6% | N/A | |
 Community Health Systems, Inc. NYSE:CYH | 48.00M | -36.9% | -18.2% | N/A | |
 Owens & Minor, Inc. NYSE:OMI | 5.33M | N/A | -37.3% | -22.0% | |
 Semler Scientific, Inc. NASDAQ:SMLR | 6.99M | 25.7% | 25.6% | N/A | |
 The Oncology Institute, Inc. NASDAQ:TOI | -131.00K | N/A | N/A | N/A | |
 Definitive Healthcare Corp. NASDAQ:DH | -9.96M | N/A | N/A | N/A | |
 Nakamoto Inc. NASDAQ:NAKA | 0.00 | N/A | N/A | N/A |
Agilon Health, Inc. Fair Value Envelope
Related Guides
Continue your AGL research with focused valuation guides.
Research Paths
Snapshot
Start with context, operating signals, and key market metrics.
Value Model
Stress test fair value across bear, base, and bull assumptions.
Statements
Validate revenue quality, margins, and balance sheet durability.
Earnings Call
Read management commentary and compare it with reported outcomes.
Dividends
Check payout sustainability and long-term distribution behavior.
Analyst Expectations
Review consensus spread and where estimate risk is concentrated.